Novo CEO pressed by Senate to cut costs of weight problems, diabetes medications CEO Lars Fruergaard Jørgensen explained to lawmakers the organization would look at new talks with insurers with regard to the list charges of Wegovy and copyright whenever they pledge to maintain the medicines on their own formularies. https://kethek.com/